Cadence Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-83,021
| Closed | -$1.49M | – | 721 |
|
|
2017
Q4 | $1.49M | Buy |
83,021
+26,973
| +48% | +$484K | 0.09% | 287 |
|
|
2017
Q3 | $661K | Buy |
+56,048
| New | +$661K | 0.04% | 454 |
|
|
2017
Q2 | – | Sell |
-80,482
| Closed | -$885K | – | 717 |
|
|
2017
Q1 | $885K | Sell |
80,482
-36,441
| -31% | -$401K | 0.06% | 385 |
|
|
2016
Q4 | $1.58M | Buy |
116,923
+29,249
| +33% | +$396K | 0.11% | 229 |
|
|
2016
Q3 | $1.08M | Buy |
87,674
+63,795
| +267% | +$785K | 0.08% | 291 |
|
|
2016
Q2 | $262K | Sell |
23,879
-411
| -2% | -$4.51K | 0.02% | 541 |
|
|
2016
Q1 | $265K | Hold |
24,290
| – | – | 0.02% | 567 |
|
|
2015
Q4 | $420K | Sell |
24,290
-1,693
| -7% | -$29.3K | 0.03% | 495 |
|
|
2015
Q3 | $516K | Buy |
+25,983
| New | +$516K | 0.04% | 445 |
|
|
2014
Q4 | – | Sell |
-152,632
| Closed | -$992K | – | 686 |
|
|
2014
Q3 | $992K | Sell |
152,632
-4,210
| -3% | -$27.4K | 0.05% | 412 |
|
|
2014
Q2 | $1.08M | Sell |
156,842
-17,303
| -10% | -$119K | 0.05% | 412 |
|
|
2014
Q1 | $1.25M | Buy |
174,145
+29,840
| +21% | +$213K | 0.05% | 403 |
|
|
2013
Q4 | $1.36M | Sell |
144,305
-13,860
| -9% | -$130K | 0.05% | 364 |
|
|
2013
Q3 | $987K | Buy |
158,165
+82,575
| +109% | +$515K | 0.03% | 441 |
|
|
2013
Q2 | $497K | Buy |
+75,590
| New | +$497K | 0.02% | 348 |
|